Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 19 February 2009, Vol. 113, No. 8, pp. 1699-1709.
Prepublished online as a Blood First Edition Paper on October 21, 2008; DOI 10.1182/blood-2008-02-138412.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Methods and Figures
Right arrow All Versions of this Article:
blood-2008-02-138412v1
113/8/1699    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alfano, M.
Right arrow Articles by Poli, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alfano, M.
Right arrow Articles by Poli, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted February 8, 2008
Accepted September 28, 2008

Ligand-engaged urokinase-type plasminogen activator receptor (uPAR) and activation of the CD11b/CD18 (Mac1) integrin inhibit late events of HIV expression in monocytic cells

Massimo Alfano*, Samanta A Mariani, Chiara Elia, Ruggero Pardi, Francesco Blasi, and Guido Poli

AIDS Immunopathogenesis Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
Leukocyte Biology Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
Molecular Genetics Unit, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy
Vita-Salute San Raffaele University, School of Medicine, Milan, Italy

* Corresponding author; email: alfano.massimo{at}hsr.it.

Urokinase-type plasminogen activator (uPA) signaling via its receptor uPAR inhibits late events in HIV-1 replication in acutely infected primary monocyte-derived macrophages (MDM) and promonocytic U937 cells. Here we show that U937-derived chronically infected U1 cells stimulated with phorbol myristate acetate (PMA) express integrins, uPA and soluble uPAR at levels similar to those of MDM. UPA inhibited HIV expression in U1 cells incubated with either PMA or tumor necrosis factor-{alpha} (TNF-{alpha}), but not with other HIV-inductive cytokines or lipopolysaccharide. Of interest, only PMA and TNF-{alpha}, but not other HIV-inductive stimuli, induced surface expression of the {alpha}M chain CD11b in U1 cells constitutively expressing CD18, the {beta}2 chain of the Mac-1 integrin. Like uPA, fibrinogen, a Mac-1 ligand, and M25, a peptide homologous to a portion of the {beta}-propeller region of CD11b preventing its association with uPAR, inhibited HIV virion release in PMA-stimulated U1 cells. Both uPAR siRNA and soluble anti-{beta}1/-{beta}2 mAbs abolished the anti-HIV effects of uPA, whereas CD11b siRNA reversed the anti-HIV effect of M25, but not that induced by uPA. Thus, either uPA/uPAR interaction, Mac-1 activation or prevention of its association with uPAR triggers a signaling pathway leading to the inefficient release of HIV from monocytic cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020